These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
334 related items for PubMed ID: 12378517
1. Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma. Shah RN, Badve S, Papreddy K, Schindler S, Laskin WB, Yeldandi AV. Hum Pathol; 2002 Sep; 33(9):915-20. PubMed ID: 12378517 [Abstract] [Full Text] [Related]
2. Differential expression of cytokeratins 7 and 20 and thyroid transcription factor-1 in bronchioloalveolar carcinoma: an immunohistochemical study in fine-needle aspiration biopsy specimens. Simsir A, Wei XJ, Yee H, Moreira A, Cangiarella J. Am J Clin Pathol; 2004 Mar; 121(3):350-7. PubMed ID: 15023039 [Abstract] [Full Text] [Related]
3. Villin, cytokeratin 7, and cytokeratin 20 expression in pulmonary adenocarcinoma with ultrastructural evidence of microvilli with rootlets. Tan J, Sidhu G, Greco MA, Ballard H, Wieczorek R. Hum Pathol; 1998 Apr; 29(4):390-6. PubMed ID: 9563790 [Abstract] [Full Text] [Related]
4. Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma. Saad RS, Cho P, Silverman JF, Liu Y. Am J Clin Pathol; 2004 Sep; 122(3):421-7. PubMed ID: 15362373 [Abstract] [Full Text] [Related]
9. Patterns of distribution of cytokeratins 20 and 7 in special types of invasive breast carcinoma: a study of 123 cases. Tot T. Ann Diagn Pathol; 1999 Dec; 3(6):350-6. PubMed ID: 10594286 [Abstract] [Full Text] [Related]
10. [Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung]. Zou SM, Lin DM, Lü N, Liu XY, Wen P, Liu FS. Zhonghua Yi Xue Za Zhi; 2003 Aug 10; 83(15):1350-2. PubMed ID: 12930693 [Abstract] [Full Text] [Related]
11. The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries. Groisman GM, Meir A, Sabo E. Int J Gynecol Pathol; 2004 Jan 10; 23(1):52-7. PubMed ID: 14668551 [Abstract] [Full Text] [Related]
13. [Value of thyroid transcription factor-1 in identification of the prognosis of bronchioloalveolar carcinoma]. Wang CL, Yue DS, Zhang ZF, Zhan ZL, Sun LN. Zhonghua Yi Xue Za Zhi; 2007 Sep 04; 87(33):2350-4. PubMed ID: 18036300 [Abstract] [Full Text] [Related]
14. CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma. Shin JH, Bae JH, Lee A, Jung CK, Yim HW, Park JS, Lee KY. Jpn J Clin Oncol; 2010 Mar 04; 40(3):208-13. PubMed ID: 19926591 [Abstract] [Full Text] [Related]
16. Alteration of cytokeratin 7 and cytokeratin 20 expression profile is uniquely associated with tumorigenesis of primary adenocarcinoma of the small intestine. Chen ZM, Wang HL. Am J Surg Pathol; 2004 Oct 04; 28(10):1352-9. PubMed ID: 15371952 [Abstract] [Full Text] [Related]
17. Expression of cytokeratins 7 and 20 in ovarian neoplasia. Cathro HP, Stoler MH. Am J Clin Pathol; 2002 Jun 04; 117(6):944-51. PubMed ID: 12047147 [Abstract] [Full Text] [Related]
18. The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinomas from pleural mesotheliomas. Tot T. Cancer; 2001 Nov 15; 92(10):2727-32. PubMed ID: 11745209 [Abstract] [Full Text] [Related]
19. Immunohistochemical analysis of lung carcinomas with pure or partial bronchioloalveolar differentiation. Sarantopoulos GP, Gui D, Shintaku P, Hong L, Wang YY, Yap CS, Fishbein MC. Arch Pathol Lab Med; 2004 Apr 15; 128(4):406-14. PubMed ID: 15043468 [Abstract] [Full Text] [Related]
20. Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma. Tot T. Eur J Cancer; 2002 Apr 15; 38(6):758-63. PubMed ID: 11937308 [Abstract] [Full Text] [Related] Page: [Next] [New Search]